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Abstract Kinetic properties of the monomeric enzyme dUTP-
ase from herpes simplex virus type 1 (HSV) were investigated
and compared to those previously determined for homotrimeric
dUTPases of bacterial and retroviral origins. The HSV and
Escherichia coli dUTPases are equally potent as catalysts
towards the native substrate dUTP with a kcat/KM of about
107 M31 s31 and a KM of 0.3 WM. However, the viral enzymes
are less specific than the bacterial enzyme. The HSV and E. coli
dUTPases show the same stereospecificity towards the racemic
substrate analogue dUTPKS (2P-deoxyuridine 5P-(K-thio)triphos-
phate), suggesting that they have identical reaction mechanisms.
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1. Introduction
The ubiquitous enzyme dUTPase, deoxyuridine triphos-
phate nucleotidohydrolase (EC 3.6.1.23), catalyzes the hydrol-
ysis of dUTP to dUMP and PPi [1] and plays an important
role in DNA synthesis [2]. The enzyme keeps the dUTP/dTTP
ratio low, thereby suppressing deleterious misincorporation of
uracil into DNA, which could otherwise lead to DNA frag-
mentation through excision repair and a concomitant increase
in rates of mutation and recombination [3]. The hydrolysis of
dUTP also provides dUMP, a precursor in the de novo syn-
thesis of dTTP.
dUTPase is encoded by eukaryotes and prokaryotes, and by
many viruses. In Escherichia coli [4] and Saccharomyces cere-
visiae [5], the enzyme has been shown to be essential for
viability. The retroviral dUTPase is crucial for e⁄cient repli-
cation of the virus in non-dividing cells [6^9]. dUTPase from
mammalian herpesvirus plays a role when the virus reactivates
from latency and dUTPase-de¢cient mutants show a reduced
neuroinvasiveness [10,11]. A dUTPase-dependent drug resist-
ance against 5-£uorodeoxyuridine has been found in a human
tumor cell line [12]. These observations indicate that dUTPase
may be a potential target for drugs against cancer and viruses.
Most dUTPases, studied so far, are homotrimers. The crys-
tal structures of the trimeric enzymes from E. coli [13,14],
human cells [15], and lentiviruses [16,17] show how conserved
stretches of sequence from di¡erent subunits come together
forming three identical active sites. Herpesviruses constitute
a heterogeneous group; dUTPases encoded by herpesviruses
from ¢sh [18,19] appear to conform to the homotrimeric mod-
el. The mammalian herpesviruses [20^26] are monomeric and
have in general longer polypeptide chains [27,28] with a rear-
ranged order of the conserved sequence motifs [29], implying
that the three-dimensional structures of these enzymes are
widely di¡erent. Therefore, characterization of a dUTPase
from a mammalian herpesvirus would be of immediate inter-
est.
We previously cloned the gene encoding dUTPase from a
mammalian herpesvirus, HSV, into a pET expression vector
[30] for production of the enzyme in E. coli and the recombi-
nant enzyme was puri¢ed to near homogeneity [28]. Recently,
the conditions for gene expression and extraction of the en-
zyme have been further optimized [31]. Here, we describe the
catalytic properties of pure preparations of recombinant HSV
dUTPase. The results are discussed and compared to those
reported for the homotrimeric dUTPases from E. coli [32]
and the retroviruses of equine infectious anemia (EIAV) [33]
and mouse mammary tumor (MMTV) [34].
2. Materials and methods
2.1. Chemicals
The pH indicators cresol red, nitrazine yellow, and bromocresol
purple, and 2P-deoxyuridine, uracil, dUMP, and dUDP were pur-
chased from Sigma. UTP, dUTP, dTTP, dCTP, and dCTPKS were
from Pharmacia LKB (Uppsala, Sweden). The substrate analogues
dUTPKS (racemic) and K,L-imido-dUTP were prepared as previously
described [35,36]. The monodisperse and non-ionic detergent octa-
ethylene glycol mono-n-dodecylether (C12E8, with a critical micelle
concentration of 7.1U1035 M) was obtained from Nikko Chemicals
(Japan). Other chemicals were of the highest available quality.
The nucleotides were puri¢ed on a MonoQ HR column (Pharmacia
LKB), attached to an FPLC (Pharmacia LKB) with a device for peak
integration. The column was equilibrated with 0.01 M HCl in 0.01
KCl and elution performed with a 15-ml gradient of 0.01 M to 0.2 M
HCl in 0.01 M KCl. Fractions containing nucleotide were immedi-
ately adjusted to pH 7 by adding KOH, and stored at 320‡C. Nu-
cleotide concentrations were determined spectrophotometrically.
dUTPKS, which is a racemic mixture of two stereoisomers, was di-
gested to completion using HSV dUTPase, 0.5 WM, in 250 WM Bicine,
pH 7.5^8.0, 25 WM cresol red, 5 mM MgCl2, 100 mM KCl, and 0.01%
(w/v) C12E8. The reaction products, the non-hydrolyzable stereoiso-
mers of dUTPKS and dUMPKS, were puri¢ed by the chromatography
procedure described above.
2.2. Enzymes
Recombinant HSV dUTPase was puri¢ed according to Bergman
[31] and stored at 320‡C in 20 mM HEPES, pH 7.3, 0.46 M NaCl,
10% (v/v) glycerol, 1 mM dithiothreitol (DTT), and 0.01% (w/v)
C12E8. The puri¢ed enzyme is stable for years when stored at
320‡C. Before the kinetic measurements, the storage bu¡er was di-
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luted with a solution containing 10 mM MgCl2 and 0.01% (w/v)
C12E8 and then concentrated using a dialysis bag (Spectra/por 3)
immersed in Na-carboxymethyl cellulose (Aquacide I, Behring Diag-
nostics). This procedure, repeated until the storage bu¡er was diluted
at least 50 times and the protein concentration was 0.5^2 mg/ml, gives
a higher yield of enzyme compared to dialysis or gel ¢ltration. dUTP-
ase from E. coli was prepared as described by Ho¡mann et al. [37]
and stored in 25 mM Bis-Tris, pH 7.0, 0.1 M NaCl at 320‡C.
2.3. Kinetic measurements
Measurements of dUTP hydrolysis were performed at 25‡C by
monitoring the proton production in a weakly bu¡ered solution con-
taining pH indicator using a stopped-£ow spectrophotometer (Dur-
rum Model D130, USA; Dionex Model 13000, USA) as previously
described [32,33]. The indicator-bu¡er pairs used were bromocresol
purple-MES (pH range 6.1^6.6), nitrazine yellow-MOPS (pH range
6.3^7.2) and cresol red-Bicine (pH range 6.7^9.1). The concentrations
of indicator and bu¡er were 25 WM and 250 WM, respectively, except
for bromocresol purple, which was used in a concentration of 50 WM
in 125 WM MES bu¡er. The ¢nal concentration of enzyme was 100^
200 nM, dUTP 5 or 10 WM, MgCl2 5 mM, and the ionic strength
0.1 M, obtained by adjustment with KCl. To prevent the dUTPase
from precipitating, the detergent C12E8 was added to obtain a ¢nal
concentration of 0.01% (w/v) during the reaction. The enzyme is sta-
ble for several hours in the pH range 6^9. Below pH 6, it rapidly
denatures.
2.4. Inhibition
The inhibition of HSV dUTPase by dTTP, dCTP, UTP, dUDP,
dUMP, dU, uracil, dUTPKS (the racemate and the non-hydrolyzable
stereoisomer), dUMPKS, and K,L-imido-dUTP was determined by
including the inhibitor at various concentrations in the assay mixture.
The apparent KM was determined and the inhibition constant, Ki, was
evaluated by plotting the apparent KM versus the inhibitor con-
centration. All inhibition measurements were performed at pHs
close to 8.
2.5. Hydrolysis of other nucleotides
Under the same conditions as used in the stopped-£ow measure-
ments, dTTP, dCTP, UTP (1 mM), and dUTPKS (0.15 mM) were
incubated at pH 7.5^8.0, overnight, with and without dUTPase
(0.5 WM) present. The hydrolysis products were analyzed using ion-
exchange chromatography as described in Section 2.1. The enzymic
hydrolysis could be run until completion for all substrates except for
the racemic dUTPKS, which was hydrolyzed to 50%, corresponding to
only one of the two stereoisomers being susceptible to hydrolysis. The
non-hydrolyzable isomer was incubated with dUTPase from E. coli
under equal conditions as above to decide whether the two enzymes
have the same stereospeci¢city.
3. Results and discussion
dUTPases of retroviral [16,17], prokaryotic [13,14], and eu-
karyotic [15] origin have been investigated by X-ray crystal-
lography and found to be homotrimers. A di¡erent structure
can be predicted for the dUTPases from the mammalian her-
pesviruses. These enzymes have longer polypeptide chains,
which have probably arisen by gene duplication [29], and
are enzymically active as monomers [27,28], ¢ndings arguing
for a distinctly di¡erent molecular organization. Here, we de-
scribe a kinetic study of a dUTPase from a mammalian herpes
virus, HSV. For the ¢rst time, a puri¢ed preparation of a
dUTPase from this group of viruses has been investigated.
The results, presented in Tables 1 and 2, are compared to
corresponding data available for homotrimeric dUTPases
[32^34].
For the HSV dUTPase (see Table 1), the KM for dUTP was
determined to 0.3 WM, close to the value for the E. coli dUTP-
ase (0.2 WM) and lower than the values for the EIAV (1.1 WM)
and the MMTV (0.8 WM) enzymes. The kcat for the HSV
enzyme was estimated from the Vmax and the enzyme concen-
tration, determined by UV (280 nm) measurements using the
theoretical extinction coe⁄cient (O280 = 41 820 M31 cm31), as-
suming that the enzyme is 100% active. The estimated kcat,
5^15 s31, is between those of the dUTPases from E. coli
(6^9 s31) and EIAV (25 s31) obtained from single-turnover
experiments. The speci¢city constant, kcat/KM for dUTP (see
Table 2) is, however, of the same magnitude for all three
enzymes, while the dUTPase from MMTV, analyzed by a
di¡erent approach [34], is di¡erent.
The HSV dUTPase is highly speci¢c towards dUTP. dTTP,
dCTP, UTP and dUTPKS act as competitive inhibitors in the
dUTPase reaction. Similar to dUTP, these nucleotides are
hydrolyzed to their corresponding monophosphates but at a
much slower rate (Table 1). The speci¢city constants for
dCTP and dTTP (approximately 103 M31 s31, if Ki equals
KM), are 3^4 orders of magnitude lower than for the native
substrate dUTP. The enzyme discriminates against dCTP,
which has the same molecular shape as dUTP, mainly by
poor binding (Ki = 1 mM) while the rate of hydrolysis
(kcatI2 s31) is not far from the value for dUTP. The dis-
crimination against dTTP is equally e⁄cient. The binding
appears to be slightly stronger (Ki 0.4 mM) than for dCTP
but the rate of hydrolysis is about 5 times lower (kcat6 0.4
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Table 1
Catalytic parameters (KM (WM) and kcat (s31)) or inhibition con-
stants (Ki (WM)) for viral (HSV, EIAV) and bacterial (E. coli) dUT-
Pases towards nucleoside triphosphates and uracil-containing com-
pounds
Substrate HSV E. colia EIAVb
dUTP
KM 0.3 0.2 1.1
kcat 5^15 6^9 25
dUTPKSc
KM 0.2 0.9 nd
kcat 6 0.2 0.6 nd
dTTP
KMd 400 s 20000 260
kcat 6 0.4 nd 6 0.5
dCTP
KMd 1000 4000 3000
kcat 6 2 0.6 6 2
UTP
KMd 1000 2500 nd
kcat 6 0.2 6 0.3 nd
Inhibitor
dUMP
Ki 170 1500 150
dUDP
Ki 17 15 3.6
dU
Ki 400 1000 1500
Uracil
Ki 5000 s 10000 nd
dUPNPP
Ki 0.9 5e 0.6
dUTPKSf
Ki 70 s 50 nd
dUMPKS
Ki 900 nd nd
aLarsson et al. [32].
bNord et al. [33].
cDetermined using the racemic mixture.
dKMWKi.
ePersson et al. [36].
nd, not determined.
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s31). For UTP, with a hydroxyl group at the 2P position of the
sugar moiety as the only di¡erence compared to dUTP, the
speci¢city constant is even lower than for dCTP and dTTP.
The results of the present study are in agreement with the
estimates of speci¢city constants obtained using a di¡erent,
discontinuous approach [34]. However, earlier studies using
crude extracts [20] and partially puri¢ed enzyme preparations
[27,38] have given contradicting results, deviating from those
obtained here.
Thus, dUTPase from HSV can easily discriminate between
dUTP and the other naturally occurring substrates (Table 2).
The e⁄ciency is about the same as for the retroviral dUTPase
from EIAV. The dUTPase from E. coli, on the other hand,
has an even higher speci¢city than the viral enzymes. Its po-
tency towards dUTP is about the same, but the speci¢city
constant for the other nucleotides is decreased by at least
one order of magnitude. This di¡erence between the bacterial
and the viral enzymes is notable and we would like to suggest
that it re£ects a di¡erence in the nucleotide metabolism be-
tween E. coli and the mammalian host systems used by the
viruses. In E. coli, dUTP is an obligatory intermediate in a
compulsory pathway from dCTP to dUMP, the precursor for
the de novo synthesis of thymine nucleotides, while in the
mammals the major route for synthesis of dUMP is from
dCMP. This would imply an elevated £ux through dUTP in
the bacterium, i.e. a higher enzymic activity, with a concom-
itant physiological demand for higher enzymic speci¢city to
avoid disturbances in the pools of dTTP and dCTP. The sig-
ni¢cantly lower product (dUMP) inhibition found for the
bacterial enzyme (Table 1) is also consistent with this view.
The second best substrate of HSV dUTPase is dUTPKS.
dUTPKS, which has one of the non-bridging oxygens replaced
by a sulfur, is racemic. Only one and the same stereoisomer of
dUTPKS in complex with Mg2 was found to be hydrolyzed
by HSV and E. coli dUTPases, suggesting that the enzymes
act by the same reaction mechanism. The susceptible stereo-
isomer of dUTPKS has a very low KM (0.2 WM), estimated as
an inhibition constant as well as by direct measurements in
the stopped-£ow apparatus, and an apparent kcat (0.2 s31)
about 100 times lower than for dUTP. The non-hydrolyzable
stereoisomer has a high Ki (70 WM), which probably re£ects
an inability to coordinate Mg2 or, more likely, to form a
Mg2 complex with high a⁄nity for the active site. The im-
portance of the metal ion has previously been demonstrated
by the ¢nding that metal-free dUTP is not hydrolyzed by the
E. coli enzyme and Mg2 enhances the binding of dUTP by a
factor of 100 [32].
dUDP inhibits dUTPase. The Ki is about the same for the
HSV and E. coli enzymes, while the EIAV dUTPase shows a
stronger inhibition. However, dUDP is not hydrolyzed by any
of the enzymes, even though the metal ion is present. We
believe that the di¡erence in catalytic susceptibility between
nucleoside di- and triphosphates is accounted for by a con-
served sequence motif [29] resembling the phosphate binding
loop found in nucleotide binding proteins [39]. This motif is
located in the C-terminal part of dUTPase, invisible in most
of the crystal structures [13,14,16,17] and believed to be £ex-
ible. Probably, upon binding of a nucleoside triphosphate in
complex with a divalent metal ion, this part of the enzyme
becomes ordered and a catalytic complex is formed. This idea
has recently got support from spectroscopic evidence [40] and
is also partly con¢rmed by the structures for the trimeric
human dUTPase in complex with dUMP, dUDP, or dUTP
[15], which show an additional ordering of nine amino acid
residues of the £exible C-terminus upon binding of nucleotide.
However, these complexes do not represent catalytic com-
plexes since the metal ion is missing. Furthermore, the enzyme
used is N-terminally truncated compared to native human
dUTPase. The ¢nding that the C-terminus of the human
dUTPase becomes ordered upon dUDP binding di¡ers from
the result previously obtained with the E. coli enzyme [14] and
the more recently reported structure of EIAV dUTPase [17].
A pronounced requirement for a triphosphate moiety to
form a catalytic complex is also consistent with the inhibitory
properties of a synthetic triphosphate analogue, K,L-imido-
dUTP. This compound was previously reported [36] to be a
strong inhibitor of the E. coli dUTPase. Table 1 shows that
HSV dUTPase is even more strongly inhibited, as is the EIAV
enzyme, providing additional support for detailed di¡erences
in the structure of the active sites between dUTPases of di¡er-
ent origins.
In summary, the monomeric dUTPase from HSV displays
kinetic and mechanistic properties comparable to those of
trimeric dUTPases indicating a close similarity in the struc-
tures of the active sites. Di¡erences in speci¢city occur be-
tween bacterial and viral dUTPases that can be related to
di¡erences in nucleotide metabolism. dUTPases of di¡erent
origins behave di¡erently with respect to inhibitors, a ¢eld
that will be further exploited in attempts to develop nucleotide
analogues for medical applications.
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